507 related articles for article (PubMed ID: 29942301)
21. [Epstein-Barr virus infection and lymphoproliferative disorders].
Isobe Y
Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
[TBL] [Abstract][Full Text] [Related]
22. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
[TBL] [Abstract][Full Text] [Related]
23. [EBV and immunodeficiency].
Dieudonne Y; Martin M; Korganow AS; Boutboul D; Guffroy A
Rev Med Interne; 2021 Dec; 42(12):832-843. PubMed ID: 33867195
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection.
Lino CNR; Ghosh S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638238
[TBL] [Abstract][Full Text] [Related]
25. Non-uniform
Burns DM; Ryan GB; Harvey CM; Nagy E; Hughes S; Murray PG; Russell NH; Fox CP; Long HM
Front Immunol; 2019; 10():2489. PubMed ID: 31736946
[TBL] [Abstract][Full Text] [Related]
26. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
[TBL] [Abstract][Full Text] [Related]
27. The immunology of Epstein-Barr virus-induced disease.
Taylor GS; Long HM; Brooks JM; Rickinson AB; Hislop AD
Annu Rev Immunol; 2015; 33():787-821. PubMed ID: 25706097
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
31. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
[TBL] [Abstract][Full Text] [Related]
32. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
33. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
[TBL] [Abstract][Full Text] [Related]
34. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
Yang X; Nishida N; Zhao X; Kanegane H
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
[TBL] [Abstract][Full Text] [Related]
35. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-associated lymphoproliferative disorders.
Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
[TBL] [Abstract][Full Text] [Related]
37. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
39. Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target.
Tse E; Kwong YL
Exp Mol Med; 2015 Jan; 47(1):e136. PubMed ID: 25613733
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
